US$ 24.10
oral glp 1 pfizer to discontinue danuglipron, its GLP-1 pill for obesity| STAT Danuglipron - Wikipedia
Description
Think of it like a key and lock
Zealand Pharma said Thursday a medical congress had unintentionally and temporarily published data from a Phase II clinical trial of its Boehringer Ingelheim-partnered liver disease drug survodutide

This review focuses on how GLP-1RAs impact lipid-related outcomes

Detailed data from the study are expected to be presented at an upcoming international medical meeting and submitted for publication in a peer-reviewed journal
